Home / Performance / Analytics
Analytics & Reporting
National · trends, productivity & exceptions
MTDQTDFY
▥
Sales growth (YoY)
+14.2%
▲ 3.1%
vs prior quarter
▥
Calls / day (avg)
8.4
▲ 0.6
target 8.0
▥
Call frequency / doctor/mo
2.3
▲ 0.2
core list ≥ 2.0
▥
Missed-call rate
11%
▼ 1.4%
planned vs actual
Sales & Growth Trend
Acme Pharma · last 8 months
SalesGrowth %
Promoted vs Natural
attributed sales mix
Promoted₹1.25 Cr
Natural₹0.59 Cr
Match-rate94%
Coverage & Productivity by Zone
core-list coverage
| Zone | Calls/day | Freq | Coverage | % |
|---|---|---|---|---|
| West | 9.1 | 2.6 | 92% | |
| North | 8.6 | 2.4 | 86% | |
| South | 8.0 | 2.2 | 78% | |
| East | 7.2 | 1.9 | 64% |
Top Therapy Areas
attributed sales, QTD
Cardiac
₹52 LGastro
₹41 LDiabetes
₹34 LRespiratory
₹25 LOrtho
₹18 LSales Heatmap — Zone × Therapy
attributed sales intensity, QTD
| Zone | Cardiac | Gastro | Diabetes | Respiratory | Ortho |
|---|---|---|---|---|---|
| West | ₹18L | ₹13L | ₹10L | ₹7L | ₹5L |
| North | ₹14L | ₹11L | ₹16L | ₹6L | ₹4L |
| South | ₹11L | ₹13L | ₹8L | ₹9L | ₹3L |
| East | ₹7L | ₹6L | ₹5L | ₹2L | ₹2L |
Exception Reports
requires HQ attention
⌖
Geo-fence mismatches
Check-ins logged outside doctor location radius · Rahul Verma, Amit Kulkarni flagged
6
⚠
Over-budget input requests
Sample & gift requests exceeding monthly territory cap · pending approval
3
⏳
Expiry-risk batches
Stock nearing expiry across West & North CFA depots
11
◎
Low-coverage territories
Core-list coverage below 70% · concentrated in East zone
4
●
Missed-call clusters
Repeated missed planned calls for same doctors · Sneha Iyer, Priya Nair beats
today